Absci (ABSI) Interest Coverage Ratio (2020 - 2026)
Absci (ABSI) posted Interest Coverage Ratio of 3.45 for Q1 2026, up 99.68% sequentially from 1070.38 in Q4 2025, and up 27.9% YoY from 2.69 in Q1 2025.
Powered by 
Analysis
Absci (ABSI) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Absci has reported Interest Coverage Ratio for 7 years, with the latest figure at 3.45 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 27.9% year-over-year to 3.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.79 (up 29.28% YoY) and the FY2025 annual result came in at 1.13, up 18.85% from the prior year.
- Interest Coverage Ratio rose to 3.45 in Q1 2026 per ABSI's latest filing, from 1070.38 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.42 in Q1 2024 and troughed at 1070.38 in Q4 2025.
- A 5-year average of 93.59 and a median of 4.78 in 2025 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 97.23% in 2022, down 1495.07% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 36.24 in 2022, then slumped by 316.22% to 150.85 in 2023, then tumbled by 81.08% to 273.16 in 2024, then tumbled by 291.86% to 1070.38 in 2025, then soared by 99.68% to 3.45 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 3.45, 1070.38, and 3.08 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | -17,079.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,079.00 |
| Mar 31, 2026 | -1,713.67 |
| Dec 31, 2025 | -1,070.38 |
| Sep 30, 2025 | -670.09 |
| Jun 30, 2025 | -560.59 |
| Mar 31, 2025 | -351.00 |
| Dec 31, 2024 | -273.16 |
| Sep 30, 2024 | -222.27 |
| Jun 30, 2024 | -178.14 |
| Mar 31, 2024 | -133.51 |
| Dec 31, 2023 | -121.27 |
| Sep 30, 2023 | -101.76 |
| Jun 30, 2023 | -167.92 |
| Mar 31, 2023 | -76.28 |
| Dec 31, 2022 | -73.49 |
| Sep 30, 2022 | -100.24 |
| Jun 30, 2022 | -136.91 |
| Mar 31, 2022 | -147.71 |
| Dec 31, 2021 | -131.28 |
| Sep 30, 2021 | -27.53 |